Continuous Bioprocessing Challenges

What challenges do biopharmaceutical manufacturers face when deciding to move from a fed batch process to a continuous process?

What challenges do biopharmaceutical manufacturers face when deciding to move from a fed batch process to a continuous process? Stéphanie Dubois, cell culture laboratory manager and application specialist at Pall Life Sciences, describes challenges and explains how alternative types of perfusion bioreactors can simplify the process.

Download

Pharmaceutical Technology’s 2014 Bioprocessing and Sterile Manufacturing eBook

Articles in this issue

over 11 years ago

Article

Potential Benefits Drive Interest in Continuous Manufacturing

over 11 years ago

Article

Determining Cross-Contamination Risks in Multiproduct Biopharmaceutical Facilities

over 11 years ago

Article

Achieving and Maintaining Compliance Using Continuous Monitoring Systems

over 11 years ago

Article

Optimizing the Sterilization of Liquids in Sealed Containers

over 11 years ago

Article

Using Modular Systems in Biopharmaceutical Manufacturing

over 11 years ago

Article

Determining Protein Oxidation Induced During Fill-Finish Operations

over 11 years ago

Article

Single-Use Technology in Parenteral Fill/Finish

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!